Delivery Order SPE2DB24D2205-SPE2DB24FDUFN
Award Date
5/16/24
Potential Completion Date
6/7/24
Potential Value
$9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $13,455.60, is for the delivery of GAMMAGARD S-D 10 G (IGA pharmaceutical products. The contract was awarded on a Firm Fixed Price basis and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GAMMAGARD S-D 10 G (Immunoglobulin G) medication. The $8,970.40 firm fixed-price contract has an ultimate completion date of September 6, 2024. The contract is not set aside for any specific business category. This order is likely part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,485.20 firm-fixed-price contract is for the supply of GAMMAGARD S-D 10 G (IGA), a specialty pharmaceutical product. The contract has an ultimate completion date of September 17, 2024. Amerisourcebergen Drug Corp is a large for-profit organization that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies for...
This federal contract award is for the delivery of GAMMAGARD S-D 10 G (IGA pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on June 13, 2024. The contract has a ceiling value of $8,970.40 and a completion date of July 8, 2024. The contract is a delivery order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a...
This federal contract award, valued at $36,068.40, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a delivery order for the pharmaceutical product GAMUNEX-C, a 10 gram/100 ml vial. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a delivery order contract worth $49,752.80 for the supply of GAMUNEX-C 40 gram/400 ml vials. The contract has a firm fixed price and an ultimate completion date of January 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award, valued at $17,868.75, was issued by the Medical Supply Chain organization within the Defense agency to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of GAMUNEX-C 20 gram/200 ml vials, a pharmaceutical product, with a completion date of July 16, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support...
This federal contract award, valued at $70,036.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of GAMUNEX-C 20 GRAM/200 ML VIAL 200ML, a pharmaceutical product, to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the pharmaceutical product GAMUNEX-C, a 10 gram/100 ml vial. The award is valued at $7,462.92 and has a firm fixed price pricing type with a period of performance through January 9, 2025. The contract does not have a set-aside designation, indicating...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product GAMUNEX-C 40 GRAM/400 ML VIAL 400ML. The contract, valued at $9,618.16, is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA). It has an ultimate completion date of June 26, 2024. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...